Related references
Note: Only part of the references are listed.Antimicrobial activity of plazomicin against Enterobacteriaceae-producing carbapenemases from 50 Brazilian medical centers
Andreza Francisco Martins et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2018)
Plazomicin Activity against 346 Extended-Spectrum-β-Lactamase/AmpC-Producing Escherichia coli Urinary Isolates in Relation to Aminoglycoside-Modifying Enzymes
Maria del Carmen Lopez-Diaz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)
Yunliang Zhang et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study
Hajo Grundmann et al.
LANCET INFECTIOUS DISEASES (2017)
In Vitro Activity of Neomycin, Streptomycin, Paromomycin and Apramycin against Carbapenem-Resistant Enterobacteriaceae Clinical Strains
Ya Hu et al.
FRONTIERS IN MICROBIOLOGY (2017)
Emergence of sequence type 11 Klebsiella pneumoniae coproducing NDM-1 and VIM-1 metallo-β-lactamases in a Greek hospital
C. C. Papagiannitsis et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2017)
Association between the Presence of Aminoglycoside-Modifying Enzymes and In Vitro Activity of Gentamicin, Tobramycin, Amikacin, and Plazomicin against Klebsiella pneumoniae Carbapenemase-and Extended-Spectrum-β-Lactamase-Producing Enterobacter Species
Ghady Haidar et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Evaluation of apramycin activity against carbapenem-resistant and -susceptible strains of Enterobacteriaceae
Kenneth P. Smith et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2016)
Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece
Theodoros Karampatakis et al.
FUTURE MICROBIOLOGY (2016)
Aminoglycoside Resistance The Emergence of Acquired 16S Ribosomal RNA Methyltransferases
Yohei Doi et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2016)
Characterization of Tn3000, a Transposon Responsible for blaNDM-1 Dissemination among Enterobacteriaceae in Brazil, Nepal, Morocco, and India
Juliana Coutinho Campos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Carbapenem-Resistant Klebsiella pneumoniae Strains Exhibit Diversity in Aminoglycoside-Modifying Enzymes, Which Exert Differing Effects on Plazomicin and Other Agents
Reem Almaghrabi et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
Ilias Karaiskos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2014)
The Balkan region: NDM-1-producing Klebsiella pneumoniae ST11 clonal strain causing outbreaks in Greece
Evangelia Voulgari et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Emergence of NDM-producing Klebsiella pneumoniae in Greece
Panagiota Giakkoupi et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Rise and dissemination of aminoglycoside resistance: the aac(6′)-lb paradigm
Maria S. Ramirez et al.
FRONTIERS IN MICROBIOLOGY (2013)
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates
D. M. Livermore et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Synthesis and Spectrum of the Neoglycoside ACHN-490
James B. Aggen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Aminoglycoside modifying enzymes
Maria S. Ramirez et al.
DRUG RESISTANCE UPDATES (2010)
Share Paper
